ProThera Biologics
  • Home
  • Therapeutic Areas
  • Science
  • Team
  • News
Select Page

Special Announcement

by Moe Finigan | Apr 17, 2020

ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)

Read the Full Announcement

ProThera Biologics, Inc.

349 Eddy Street

Providence, RI 02903

Contact Us